Axsome Therapeutics, Inc. (AXSM)

Axsome Therapeutics, Inc. (AXSM) is a healthcare company (biotechnology) based in the United States. The share price is $136.21, down 0.58% on the day, which values the company at $7.16B. Price as of 17 Nov 2026, 17:15 UTC, from Yahoo Finance.

Key facts

Share price
$136.21−0.58% today
Market value
$7.16B
Forward P/E
37.3×
Funk Score
54/100
Against its own history
About its usual priceusual price $132.78
200-week average
$115.1718% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Axsome Therapeutics, Inc. in more detail

AXSM trades at 37.3× next year's expected earnings, 8.3× sales. Measured against its own history, the price is 3% above what its usual multiples would imply ($132.78) — about its usual price. It sits 18% above its 200-week average of $115.17.

Its Funk Score is 54 out of 100 (financial strength 6.4, profitability 2.5, growth 10.0, value 2.6, each out of 10).

In its favour: Altman Z in the safe zone; Operating margin is expanding. Worth checking: Share count keeps rising; Thin interest cover.

Compare

Health Care companies of similar size

Side by side:AXSM vs CHE (Axsome Therapeutics, Inc. vs Chemed)AXSM vs ORKA (Axsome Therapeutics, Inc. vs Oruka Therapeutics)AXSM vs ARWR (Axsome Therapeutics, Inc. vs Arrowhead Pharmaceuticals)AXSM vs IMVT (Axsome Therapeutics, Inc. vs Immunovant)AXSM vs MSA (Axsome Therapeutics, Inc. vs MSA Safety)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

Axsome Therapeutics, Inc. (AXSM): questions and answers

What is Axsome Therapeutics, Inc.'s market cap?

Axsome Therapeutics, Inc. is valued at $7.16B at a share price of $136.21.

Is AXSM overvalued or undervalued?

Against its own history, AXSM is about its usual price: the price is 3% above the $132.78 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is AXSM above its 200-week moving average?

Yes. AXSM is 18.3% above its 200-week average of $115.17. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Axsome Therapeutics, Inc. growing?

Over the last three fiscal years Axsome Therapeutics, Inc.'s revenue grew 133.7% a year.

Does AXSM pay a dividend?

Axsome Therapeutics, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Axsome Therapeutics, Inc. (AXSM) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/AXSM

Underlying data: Yahoo Finance; company filings with the SEC.